Basic Information
ForSight VISION5 was founded in 2010 as the fifth company created by ophthalmic product incubator ForSight Labs. ForSight VISION5 is developing non-invasive alternatives to eye drops, providing sustained treatment for major eye conditions including glaucoma, dry eye, and allergies. The company is currently conducting its second Phase II clinical study for its lead product, Helios.
ForSight VISION5, Inc.
California,United States of America
15~50 people
January 01, 2010
information@forsightv5.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios